These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods. Festi D; Schiumerini R; Marzi L; Di Biase AR; Mandolesi D; Montrone L; Scaioli E; Bonato G; Marchesini-Reggiani G; Colecchia A Aliment Pharmacol Ther; 2013 Feb; 37(4):392-400. PubMed ID: 23278163 [TBL] [Abstract][Full Text] [Related]
7. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244 [TBL] [Abstract][Full Text] [Related]
8. Clinical spectrum and therapy of non-alcoholic steatohepatitis. Day CP Dig Dis; 2012; 30 Suppl 1():69-73. PubMed ID: 23075871 [TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of non-alcoholic steatohepatitis and basis for treatment. Pinzani M Dig Dis; 2011; 29(2):243-8. PubMed ID: 21734391 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Musso G; Gambino R; Cassader M; Pagano G Ann Med; 2011 Dec; 43(8):617-49. PubMed ID: 21039302 [TBL] [Abstract][Full Text] [Related]
11. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Younossi ZM Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557 [TBL] [Abstract][Full Text] [Related]
12. Review article: diagnosis and treatment of non-alcoholic fatty liver disease. Oh MK; Winn J; Poordad F Aliment Pharmacol Ther; 2008 Sep; 28(5):503-22. PubMed ID: 18532991 [TBL] [Abstract][Full Text] [Related]
16. [Non-alcoholic fatty liver disease--new view]. Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346 [TBL] [Abstract][Full Text] [Related]
17. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117 [TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease. Leclercq I Bull Mem Acad R Med Belg; 2010; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266 [TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Weiner RA Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923 [TBL] [Abstract][Full Text] [Related]
20. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Verna EC; Berk PD Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]